KEWPIE CORP

Overview

KEWPIE CORP is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering HYALURONSAN HA-AM (SODIUM HYALURONATE); HYALURONSAN HA-AML(SODIUM HYALURONATE) DRUG SUBSTANCE; HYALURONSAN HA-SHL (SODIUM HYALURONATE).

API / Drug Master Files

KEWPIE CORP holds 3 active (4 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• HYALURONSAN HA-SHL (SODIUM HYALURONATE)Active2018-12-31
• HYALURONSAN HA-AML(SODIUM HYALURONATE) DRUG SUBSTANCEActive2016-04-22
• HYALURONSAN HA-AM (SODIUM HYALURONATE)Active2000-02-29
• ETHYL ICOSAPENTATE DRUG SUBSTANCEInactive2016-06-01

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to KEWPIE CORP in our records. PharmaTek screens the full directory against live FDA enforcement data.